講題 | 主講人 | |
---|---|---|
※研討會內容著作權屬於講者,請遵守著作財產權法規,未經同意不得重製、利用或散佈。 | ||
08:50– 09:00 |
Opening Remarks |
Dr. Jih-Haw Chou 周志浩 常務次長 Ministry of Health and Welfare |
Keynote Speech 1 | ||
09:00– 09:40 |
Neoantigen-targeting Vaccines, Antibodies and TCR-engineered T Cell Therapy |
Dr. Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition, Japan |
Keynote Speech 2 | ||
09:40– 10:20 |
Cancer Prevention: Targeting Cancer in Rare Diseases |
Dr. Jean Y. Tang Department of Dermatology, Stanford University School of Medicine, U.S.A. |
Session 1: Nucleic Acid Therapeutics | ||
10:40– 11:05 |
mRNA-4157 (V940) Individualized Neoantigen Therapy: mRNA Therapeutics Coming of Age in Cancer |
Dr. Raquel Deering Moderna Cancer Vaccine Research, U.S.A. |
11:05– 11:30 |
The Potential and Challenges of CRISPR Gene Therapy for HBV Cure |
Dr. Hung-Chih Yang 楊宏志 教授 National Taiwan University Cancer Center, Taiwan |
11:30– 11:55 |
Preclinical Development of DNA Vaccines |
Dr. Shih-Jen Liu 劉士任 副所長 National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Taiwan |
Poster Discussion and Media Interview | ||
11:55– 12:30 |
Selected Poster Oral Presentation Discussion and Media Interview |
Dr. Pan-Chyr Yang 楊泮池 院士 Dr. Hwei-Fang Tien 田蕙芬 教授 Dr. Pan-Chyr Yang 吳俊穎 副院長 Dr. Pan-Chyr Yang 劉柯俊 副所長 |
講題 | 主講人 | |
---|---|---|
Keynote Speech 3 | ||
13:40– 14:20 |
Targeting Immunotherapy to the Tumor Microenvironment |
Dr. Lieping Chen 陳列平 院士 Department of Immunobiology, Yale School of Medicine, U.S.A. |
14:20– 14:45 |
Tailoring T Cell Anti-tumor Immunity by Re-wiring Mitochondrial Dynamics |
Dr. Ping-Chih Ho 何秉智 教授 Ludwig Institute for Cancer Research, University of Lausanne, Switzerland |
14:45– 15:10 |
Novel Target for Dendritic Cell-based Cancer Immunotherapy |
Dr. Tai-Lung Cha 查岱龍 教授 National Defense Medical Center, Taiwan |
15:10– 15:35 |
Immunotherapy Revolutionized Stage 1-4 Lung Cancer Treatment |
Dr. James Chih-Hsin Yang 楊志新 院長 National Taiwan University Cancer Center, Taiwan |
Session 3: Clinical and Public Health | ||
15:55– 16:20 |
Avatar Medicine: Organ/Tumor on Chip Re-constructing Micro-environment in Vitro for Disease Model and Drugs Tests |
Dr. Cheng-Hsien Liu 劉承賢 教授 Department of Power Mechanical Engineering, National Tsing Hua University, Taiwan |
16:20– 16:45 |
The Impact of nCoV-19 on Pancreatic Cancer Treatment: NCKUH's Experience |
Dr. Yan-Shen Shan 沈延盛 院長 College of Medicine, National Cheng Kung University, Taiwan |
16:45– 17:10 |
Cancer Research: from Precision Medicine to Precision Health |
Dr. Chun-Ying Wu 吳俊穎 副院長 College of Medicine, National Yang Ming Chiao Tung University, Taiwan |
17:00– 17:10 |
Closing Remarks |
Dr. Huey-Kang Sytwu 司徒惠康 院長 National Health Research Institutes, Taiwan |